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EVIDENCE-BASED	PHARMACOTHERAPY	IN	PRETERM	INFANTS	
Aiming	at	a	moving	target	
	
1. Optimal	drug	dosage	for	preterm	infants	should	be	based	on	the	best	available	
evidence	instead	of	the	manufacturer’s	label.	[this	thesis]	
	
2. Considerable	dosage	reductions	are	required	for	fentanyl	and	doxapram	during	the	first	days	
of	life	to	achieve	a	comparable	exposure.	[this	thesis]	
	
3. Evaluation	of	doxapram	therapy	has	changed	from	a	subjective	to	an	objective	approach	by	
using	high	frequency	monitor	data.	[this	thesis]	
	
4. Consensus	on	prescription	practice	should	be	the	first	step	towards	a	better	and	safer	
treatment	of	this	vulnerable	population.	[this	thesis]	
	
5. Bayesian	forecasting	and	simulation	may	be	powerful	tools,	but	its	translation	ability	is	
limited	by	the	developed	model.	[this	thesis]		
	
6. ‘Knowing	is	not	enough;	we	must	apply.	Willing	is	not	enough;	we	must	do.’	[Goethe]	
	
7. In	this	digital	era,	treatment	data	of	all	(pediatric)	patients	worldwide	should	be	collected	
and	could	provide	a	strong	basis	to	continuously	optimize	health	care.	
	
8. To	reach	a	port	we	must	set	sail	-	Sail,	not	tie	at	anchor	-	Sail,	not	drift.	[Franklin	D.	
Roosevelt]	
	
9. The	time	has	come	to	protect	children	and	young	people	through	research	not	from	
research.	[Bobbie	Farsides]	
	
10. Doctors	without	pharmacists	are	like	a	general	without	an	artillery.	[Hugo	van	der	Kuy]	
	
11. A	PhD	project	is	like	travelling	with	the	Dutch	Railways	(NS):	You	will	reach	your	destination	
eventually,	although	beforehand	you	do	not	which	way,	with	whom	and	when.		
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